January 9, 2024 — Unfortunately, we are facing the new year with a great demand for advanced new obesity medicines and an inadequate supply. On the FDA drug shortages website, all strengths of the Wegovy brand, except 2.4 mg, have limited availability. Both Wegovy and Ozempic are “currently in shortage.” This opens the door for compounded semaglutide and a […]
November 15, 2023 — A trip into the world of pharmacy benefit managers (PBMs) is enough to make our heads spin. It leads us to wonder: exactly who benefits from pharmacy benefit managers? The answer is not clear, but it seems obvious that patients in need of affordable medicine do not. In Search of a Fair Deal The biggest […]
May 12, 2022 — Somehow this doesn’t seem right. The list price for for a month’s supply of semaglutide when it’s for diabetes is $892. No matter whether you need a dose of 1 mg, or the new high dose of 2 mg, the price is the same. It goes under the brand name of Ozempic and comes from […]
October 28, 2020 — It’s that time of year. Many people are picking health plans. For folks who get health insurance through their employer, that might mean looking through confusing options to pick the one that best suits their needs. For others with Medicare, that might mean choosing between insurance options that provide better coverage than bare bones Medicare. […]
September 28, 2020 — The CEO of Whole Foods, John Mackey, is offering up wisdom for the world on obesity in the New York Times. The whole world is getting fat, he says. But according to him, it’s definitely not a problem of access to healthful foods: “People have got to become wiser about their food choices. And if […]
March 18, 2017 — Workplace wellness has been creating headlines this week, due to legislation about genetic testing in these programs. In a guest blog today, our friend Al Lewis writes about his concerns with the industry. This week, Fortune published a generally very skeptical review of workplace wellness, highlighting one of the few major companies (Cummins) to be moving […]
